An unexpected increased HCC recurrence and occurrence rate among HCV patients treated with direct acting antivirals combination has been reported. Aim of the study was the evaluation of early HCC occurrence rate and its risk factors in a HCV infected population, treated with direct-acting-antivirals.
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: A prospective multicentre study / Rinaldi, L.; Perrella, A.; Guarino, M.; De Luca, M.; Piai, G.; Coppola, N.; Pafundi, P. C.; Ciardiello, F.; Fasano, M.; Martinelli, E.; Valente, G.; Nevola, R.; Monari, C.; Miglioresi, L.; Guerrera, B.; Berretta, M.; Sasso, F. C.; Morisco, F.; Izzi, A.; Adinolfi, L. E.. - In: JOURNAL OF TRANSLATIONAL MEDICINE. - ISSN 1479-5876. - 17:1(2019), p. 292. [10.1186/s12967-019-2033-x]
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: A prospective multicentre study
Guarino M.;Morisco F.;
2019
Abstract
An unexpected increased HCC recurrence and occurrence rate among HCV patients treated with direct acting antivirals combination has been reported. Aim of the study was the evaluation of early HCC occurrence rate and its risk factors in a HCV infected population, treated with direct-acting-antivirals.| File | Dimensione | Formato | |
|---|---|---|---|
|
rINALDI OCCURRENCE.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
718.23 kB
Formato
Adobe PDF
|
718.23 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
